Embolization with “Ethibloc” of vascular tumors and arteriovenous malformations in the head and neck
✍ Scribed by D. Kühne; K. Helmke
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 555 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0028-3940
No coin nor oath required. For personal study only.
✦ Synopsis
"Ethibloc" has been used almost exclusively until now for embolization of tumors and bleeding vessels in the liver and kidney. Unlike with Gelfoam-particles, there is no recanalization. The resorption occurs so slowly that there is no interference with the necrosis of the embolized tumor. Due to its low viscosity, it passes catheters with thin lumina and fills the capillary bed of the tumor without danger danger of reaching the venous vessels. In this paper we describe a new technic of percutaneous catheter-embolization with Ethibloc using a coaxial catheter which we believe enhances safety and effectiveness. It has been successfully used in five patients. In the meantime two more patients have been treated successfully.
📜 SIMILAR VOLUMES
## Abstract Vascular anomalies are among the most common congenital and neonatal dysmorphogenesis, which are separated into hemangiomas and vascular malformations. They can occur in various areas throughout the body, with 60% being located in the head and neck. The true mechanism of pathogenesis of
Background. The purpose of this study was to evaluate the outcomes of dacryocystorhinostomy (DCR) in patients with head and neck tumors. Methods. The clinical records of all 31 patients with head and neck tumors who underwent DCR for nasolacrimal duct blockage at The University of Texas M. D. Ander
## Abstract ## Background and Objectives Photodynamic therapy is based on an interaction of a drug and light in oxygenated tissue. The photosensitizing drug Foscan® is licensed in the EU for the treatment of advanced head and neck cancer. The light can be applied by surface illumination or directl